Pharmaceutical

Prilenia and Ferrer to commercialise pridopidine in Europe

Prilenia has signed a partnership and licence agreement with Ferrer for jointly developing and commercialising pridopidine in Europe.

Apr 30, 2025 - 06:00
Prilenia and Ferrer to commercialise pridopidine in Europe
Prilenia has signed a partnership and licence agreement with Ferrer for jointly developing and commercialising pridopidine in Europe.
Read the original article

Tags:

Previous Article

Biohaven secures $600m financing as it awaits FDA prodrug decision

Next Article

EC conditionally approves Regeneron’s Lynozyfic for multiple myeloma

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Lawmakers eye partial increase for Medicare doctor pay

STAT+: Lawmakers eye partial increase for Medicare doct...

Feb 13, 2024

STAT+: Pharmalittle: Biden’s NIH nominee will get a hearing; top Democrat backs bill to ban PBM spread pricing

STAT+: Pharmalittle: Biden’s NIH nominee will get a hea...

Sep 12, 2023

STAT+: UnitedHealth says medical costs aren’t soaring. The reality is murkier

STAT+: UnitedHealth says medical costs aren’t soaring. ...

Apr 15, 2023